Symposium |Optimizing chronic lymphocytic leukemia management in a changing landscape
On June 22, 2026, the Lymphoma Hub held a virtual symposium, titled Optimizing treatment for chronic lymphocytic leukemia with BTK inhibitors. During the symposium, Lymphoma Hub Steering Committee mem...
20 Elo 23min
Symposium | BTK inhibitors in practice: Treatment selection and emerging clinical evidence
On June 22, 2026, the Lymphoma Hub held a virtual symposium, titled Optimizing treatment for chronic lymphocytic leukemia with BTK inhibitors. During the symposium, Farrukh Awan, University of Texas S...
12 Elo 27min
Symposium | BTK inhibitors in CLL: Mechanisms, clinical considerations, and unmet needs
On June 22, 2026, the Lymphoma Hub held a virtual symposium, titled Optimizing treatment for chronic lymphocytic leukemia with BTK inhibitors. During the symposium, Lymphoma Hub Steering Committee mem...
12 Elo 12min
EHA 2026 | What are the key findings from the DALY 2-EU trial of zamto-cel in R/R LBCL?
The Lymphoma Hub was pleased to speak with Gloria Iacoboni, Vall d'Hebron University Hospital, Barcelona, ES. We asked, What are the key findings from the DALY 2-EU trial of zamtocabtagene autoleucel ...
21 Heinä 8min
EHA2026 | What are the key findings from the subgroup analysis of the EPCORE FL-1 trial in R/R FL?
Following the European Hematology Association (EHA) 2026 Congress, June 11–14, 2026, Stockholm, SE, the Lymphoma Hub spoke with Lorenzo Falchi, Memorial Sloan Kettering Cancer Center, New York, US. We...
16 Heinä 10min
Zanubrutinib for patients with previously untreated CLL/SLL: Insights from the SEQUOIA trial
During the Lymphoma Hub Steering Committee Meeting on April 20, 2026, key opinion leaders met to discuss results from the long-term follow-up of the phase III SEQUOIA trial (NCT03336333) evaluating za...
10 Heinä 26min
EHA 2026 | What are the key findings from the phase I ANTLER trial in R/R B-cell NHL?
During the European Hematology Association (EHA) 2026 Congress, June 11–14, 2025, Stockholm, SE, the Lymphoma Hub spoke with Stephen Schuster, University of Pennsylvania, Philadelphia, US. We asked, W...
1 Heinä 5min
Annual oncology meeting | Key highlights in lymphoma
During the American Society of Clinical Oncology Annual Meeting, May 19 – June 2, 2026, Chicago, US, the Lymphoma Hub was pleased to speak with Joshua Brody from the Icahn School of Medicine at Mount ...
22 Kesä 11min
